Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients
- 19 February 2004
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 150 (2) , 374-376
- https://doi.org/10.1111/j.1365-2133.2003.05766.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Local treatments for cutaneous warts: systematic review * Commentary: Systematic reviewers face challenges from varied study designsBMJ, 2002
- Vitamin D and systemic cancer: is this relevant to malignant melanoma?British Journal of Dermatology, 2002
- Topical preparations for the treatment of psoriasis: a systematic reviewBritish Journal of Dermatology, 2002
- Guidelines for the management of cutaneous wartsBritish Journal of Dermatology, 2001
- Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparatorBritish Journal of Dermatology, 1999
- Retinoids, interferon α, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RARα mediates the antiangiogenic effect of retinoidsCancer Letters, 1995
- Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesionsThe Lancet, 1994